B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Katanin

299 PubMed studies analyzed ยท Evidence Score: 43.6

Research Domains

Katanin has been studied across 15 research domains including ๐Ÿ”ฌ Oncology, โšก Energy & Fatigue, ๐Ÿง  Neuroprotection, โณ Longevity & Aging, โ™€โ™‚ Sexual Health. The primary research focus is ๐Ÿ”ฌ Oncology with 8% of studies addressing this area.

Loading evidence profile...

This evidence profile for Katanin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.